abstract |
An oral pharmaceutical composition comprising a controlled release formulation of one or more fumarate esters, wherein the one or more fumarate esters are suspended in a one phase liquid matrix comprising a lipid or lipophilic vehicle, wherein the Matrix is encapsulated in an enteric soft capsule. |